Pharma's UK reputation in tact as pandemic legacy lives on

The pharma sector continues to maintain strong levels of public trust and favorability among Britons, according to the Association of the British Pharmaceutical Industry (ABPI) UK Pharma Reputation Index.

Opinions showed consistent recognition of the sector’s support for the National Health Service (NHS), with 67% of respondents saying the industry is committed to developing new medicines to meet patient needs.

"There is much optimism – and great expectations – about pharma’s ability to tackle future crises"Overall, positive public sentiment has increased, with favorability up to 53% from 50% a year ago, and similar gains across familiarity, trust and advocacy.